- Ownership
- Activity
GSK Stock Ownership Activity
GLAXOSMITHKLINE PLC-SPON ADR 13F holders
No value investing guru has made any change to the GLAXOSMITHKLINE PLC-SPON ADR (GSK) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying GSK now?
According to the latest SEC filing(s) GLAXOSMITHKLINE PLC-SPON ADR (GSK) has not been purchased by any super investor.
To see more about who is investing in GLAXOSMITHKLINE PLC-SPON ADR (GSK), please go to the GSK ownership page.
2020 Q1
(3 results)
AVG reported price*: $47.36
2019 Q4
(4 results)
AVG reported price*: $58.74
2019 Q3
(4 results)
AVG reported price*: $53.35
2019 Q2
(3 results)
AVG reported price*: $50.02
2019 Q1
(3 results)
AVG reported price*: $52.24
2018 Q4
(3 results)
AVG reported price*: $47.76
2018 Q3
(3 results)
AVG reported price*: $50.21
2018 Q2
(3 results)
AVG reported price*: $50.39
2018 Q1
(3 results)
AVG reported price*: $48.84
2017 Q4
(3 results)
AVG reported price*: $44.34
2017 Q3
(3 results)
AVG reported price*: $50.75
2017 Q2
(3 results)
AVG reported price*: $53.90
2017 Q1
(4 results)
AVG reported price*: $52.70
2016 Q4
(3 results)
AVG reported price*: $47.72
2016 Q3
(3 results)
AVG reported price*: $53.98
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.